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Synopsis
G-protein coupled receptors (GPCRs) constitute the largest class of membrane proteins and are a major drug target.
A serious obstacle to studying GPCR structure/function characteristics is the requirement to extract the receptors
from their native environment in the plasma membrane, coupled with the inherent instability of GPCRs in the de-
tergents required for their solubilization. In the present study, we report the first solubilization and purification of a
functional GPCR [human adenosine A2A receptor (A2AR)], in the total absence of detergent at any stage, by exploiting
spontaneous encapsulation by styrene maleic acid (SMA) co-polymer direct from the membrane into a nanoscale SMA
lipid particle (SMALP). Furthermore, the A2AR–SMALP, generated from yeast (Pichia pastoris) or mammalian cells, ex-
hibited increased thermostability (∼5 ◦C) compared with detergent [DDM (n-dodecyl-β -D-maltopyranoside)]-solubilized
A2AR controls. The A2AR–SMALP was also stable when stored for prolonged periods at 4 ◦C and was resistant to
multiple freeze-thaw cycles, in marked contrast with the detergent-solubilized receptor. These properties establish
the potential for using GPCR–SMALP in receptor-based drug discovery assays. Moreover, in contrast with nanodiscs
stabilized by scaffold proteins, the non-proteinaceous nature of the SMA polymer allowed unobscured biophysical
characterization of the embedded receptor. Consequently, CD spectroscopy was used to relate changes in secondary
structure to loss of ligand binding ([3H]ZM241385) capability. SMALP-solubilization of GPCRs, retaining the annular
lipid environment, will enable a wide range of therapeutic targets to be prepared in native-like state to aid drug
discovery and understanding of GPCR molecular mechanisms.
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INTRODUCTION
G-protein coupled receptors (GPCRs) constitute the largest class
of membrane proteins in the human genome with >800 unique re-
ceptors. They are activated by an extremely diverse range of stim-
uli which differ with respect to their physico-chemical properties
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and size; ranging from photons, through small biogenic amines
to peptides and glycoproteins [1]. GPCRs share a common pro-
tein architecture comprising seven transmembrane helices and
are represented in the genome of organisms from viruses and
slime moulds to plants and humans. Consequently, these recept-
ors are central to cell signalling and as such are important to the
pharmaceutical industry as therapeutic targets in drug discovery
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programs. Indeed, 40 %–50 % of clinically-prescribed drugs and
∼25 % of the top selling drugs target this protein family [2].
A pre-requisite to a detailed understanding of the molecular
mechanisms underlying ligand binding, receptor activation and
intracellular signalling is the ability to study the receptor protein
in isolation while preserving the GPCR protein-fold and pharma-
cology. Extracting GPCRs from the cell membrane to produce a
solubilized preparation for studying receptor structure and func-
tion has universally involved the use of a class of surfactants
often referred to as detergents. These detergents not only dis-
rupt the cell membrane but also simultaneously substitute for the
native lipid in close association with the membrane protein (an-
nular lipid). Unfortunately, inserting a protein into a detergent
micelle provides only a poor approximation of the cell mem-
brane bilayer and the native annular lipid. Indeed, it is thought
that delipidation may be the most common cause of membrane
protein inactivation during solubilization [3]. Once solubilized by
a detergent, all subsequent studies require the continued presence
of detergent to prevent receptor aggregation, despite the prob-
lems this causes with respect to receptor stability. This inherent
instability of GPCRs in detergent micelles was the motivation
for the development a new class of detergent, maltose-neopentyl
glycol amphiphiles, designed specifically to improve GPCR sta-
bility during solubilization and crystallization studies [4]. An
alternative strategy is to exchange the detergent used to solubil-
ize GPCRs [often n-dodecyl-β-D-maltopyranoside (DDM)] with
a non-conventional surfactant, such as amphipathic polymers
(amphipols) or fluorinated surfactants [5,6]. The use of these
non-conventional surfactants does not obviate the use of clas-
sical detergents however, as amphipols and fluorinated surfact-
ants are usually incapable of solubilizing proteins directly from
the plasma membrane [3]. Using an alternative strategy, an engin-
eered β-sheet peptide was used to stabilize detergent-solubilized
membrane proteins, including the glucagon receptor [7]. Another
approach, pioneered by the Sligar laboratory [8] and subsequently
utilized by other groups, is to encapsulate detergent-solubilized
receptors into nanodiscs [9–11]. Nanodiscs are nanometre-scale
planar discs of lipid bilayer stabilized by encircling membrane
scaffold protein (MSP), usually a modified form of human high-
density lipoprotein apoA-1 [12,13]. This encapsulation of GPCRs
into nanodiscs is usually performed using receptor that was pre-
viously purified in detergent. However, the parathyroid hormone
1 receptor (PTH1R) was recently purified in nanodiscs following
initial solubilization by the detergent DDM, specifically to reduce
the time the PTH1R was exposed to detergent [14]. Nevertheless,
a general limitation of nanodiscs is that interference from the
obligatory stabilizing scaffolding protein prevents or perturbs
the downstream application of many biophysical approaches to
study the encapsulated protein of interest.
There has been an absolute requirement for detergent to sol-
ubilize GPCRs despite the universal acknowledgement that ex-
posing GPCRs to detergent perturbs and destabilizes the receptor.
Although significant progress has been made to reduce the det-
rimental impact of detergent by employing non-conventional
surfactants or nanodiscs, the ideal situation would be to gen-
erate GPCRs in aqueous solution in a native-like state, complete
with annular lipid, but without any exposure to detergent. In the
present study, we report the first solubilization and purification
of a GPCR, the human adenosine A2A receptor (A2AR), without
the use of detergent at any stage by exploiting spontaneous en-
capsulation of a GPCR direct from a membrane into a nanoscale
styrene maleic acid (SMA) lipid particle (SMALP). This gener-
ates a nano-section of the native membrane excised and stabil-
ized by a ring of SMA polymer [15]. In addition, we demonstrate
the utility of our approach by applying SMALP-solubilization
to two applications fundamentally important to GPCR research:
(i) purification of milligram amounts of functional GPCR from a
commonly employed overexpression system (yeast) and (ii) solu-
bilization of GPCR from transfected mammalian cells in culture,
with retention of the annular native membrane environment, for
downstream applications, such as drug discovery assays.
EXPERIMENTAL
Materials
[3H]ZM241385 (specific activity 50.0 Ci/mmol) was pur-
chased from American Radiolabelled Chemicals. ZM241385
{4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-
yl amino]ethyl)phenol} was purchased from Tocris, xanthine
analogue congener (XAC), 5’-(N-ethylcarboxamido)adenosine
(NECA) and theophylline from Sigma. Cell culture media,
buffers and supplements were purchased from Invitrogen.
Restriction enzymes were obtained from NEB.
Expression of A2AR in P. pastoris
General protocols for heterologous expression of A2AR in P.
pastoris were as described in the Pichia Fermentation Pro-
cess Guidelines (Invitrogen) or as described previously [16,17].
The human A2AR was expressed with an N-terminal His10-
tag in the pPICZαA expression plasmid and incorporated an
Asn154Gln mutation to preclude hyperglycosylation [18]. The
A2AR–pPICZαA expression plasmid was linearized, purified and
used to transform P. pastoris strain X-33 by electroporation.
Colonies were selected on yeast extract peptone dextrose sor-
bitol plates containing 0.1 mg/ml Zeocin and then used for re-
ceptor expression screening. Small-scale screening and protein
detection was carried out as described previously [16] with the
following modifications; the induction temperature was lowered
to 22 ◦C and the A2AR antagonist theophylline (10 mM) was ad-
ded at the point of induction [18]. For large-scale expression
of A2AR, frozen glycerol stock culture was used to inoculate
50 ml of buffered complex glycerol medium (1 % yeast extract,
2 % peptone, 1.34 % yeast nitrogen base without amino acids,
0.00 004 % biotin, 1 % glycerol, 0.1 M phosphate buffer, pH 6)
containing 100 μg/ml Zeocin. The cells were grown at 30 ◦C and
220 rpm overnight to yield an optical density at 600 nm (D600) of
2–6. A 50 ml aliquot of this culture was used to inoculate a 1 l
of fermenter (Applikon) containing basal salts medium (BSM)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2 c© 2015 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/)
which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Detergent-free solubilization of GPCRs
plus Pichia trace minerals 1 (PTM1) trace salts to a starting D600
of 0.3. The fermentation run in ‘fed-batch’ mode at 30 ◦C and
pH 5.0 was maintained using undiluted (28 %) ammonium hy-
droxide. Dissolved oxygen (DO) was maintained above 20 %
saturation by adjusting agitation rate and pure oxygen supply.
When the initial glycerol (40 g/l) in batch phase was depleted,
as indicated by a spike in DO reading, a 50 % (w/v) glycerol solu-
tion containing 1.2 % (v/v) PTM1 was introduced at a feed rate of
30 ml/h for 4 h. Glycerol feed was terminated followed by a 3 h
starvation phase to achieve complete glycerol consumption. Dur-
ing the final hour of starvation, the temperature was reduced from
30 ◦C to 22 ◦C and allowed to stabilize. Theophylline (10 mM)
was then added to the culture to increase A2AR stabilization dur-
ing expression. The cells were induced with 100 % methanol
containing 1.2 % (v/v) PTM1 at an initial feed rate of 1.92 ml/h
for 17 h to allow culture adaptation to methanol. When a steady
DO rate and fast DO spike time was obtained, indicative of ad-
aptation to methanol utilization, the feed rate was increased to
3.96 ml/h for the remainder of the fermentation. The entire meth-
anol ‘fed-batch’ phase lasted approximately 40 h with a total of
∼125 ml of methanol fed per litre of initial volume. The cells
were then harvested by centrifugation at 6000 g in a Beckman
JLA-8.1 rotor and washed once with 10 mM Tris/HCl buffer,
pH 8.
Yeast Membrane preparation
Yeast cells expressing A2AR were disrupted as described previ-
ously [16]. The membranes were resuspended to 80 mg/ml in
50 mM Tris/HCl, 10 % glycerol, 500 mM NaCl, pH 8 and used
immediately for SMA solubilization or snap-frozen and stored at
− 80 ◦C until further use.
HEK293T cell culture and transfection
Human embryonic kidney (HEK)293T cells were routinely cul-
tured in Dulbecco’s modified Eagles medium (DMEM) con-
taining L-glutamine (2 mM), D-glucose (4500 mg/l) and sodium
pyruvate (1mM) supplemented with 10 % (v/v) fetal calf serum
(FCS) in humidified 5 % (v/v) CO2 in air at 37 ◦C. Transfection
was essentially as described previously [19]. Cells were seeded
at a density of ∼5 × 105 cells/100-mm dish and transfected after
48 h using a mixture of 5 μg of DNA, 60 μl of polyethyleneimine
(10 mM) and 1 ml of 5 % glucose solution, which was incubated
for 30 min at room temperature before addition to an appropri-
ate final volume of full media. A2AR-expressing HEK293T cells
were used 48 h post-transfection.
Preparation of styrene maleic acid co-polymer
Poly(styrene-co-maleic anhydride) with a ratio of 2:1 styrene to
maleic anhydride was used as described in [15]. Briefly, a 10 %
solution of SMA co-polymer in NaOH (1 M) was refluxed for 2 h
and allowed to cool to room temperature, then dialysed against
buffer before use.
SMA solubilization of A2AR
A2AR-expressing yeast membranes, at a final concentration of
40 mg/ml (wet weight) were incubated with SMA (2.5 % w/v
final concentration) for 20 h at 25 ◦C with gentle stirring. Non-
solubilized material was sedimented at 100 000 g for 1 h at 4 ◦C,
to yield a supernatant containing A2AR–SMALP. HEK293T cells
transiently transfected with A2AR were washed with ice-cold PBS
48 h post-transfection, then scraped into 1 ml/dish of harvesting
buffer (20 mM HEPES, 1 mM EGTA, 1 mM magnesium acetate,
pH 7.4) containing 2 % (w/v) SMA and 5 units/ml of benzonase.
Samples were incubated at 37 ◦C for 1 h before centrifugation at
100 000 g for 1 h at 4 ◦C.
DDM solubilization of A2AR
Yeast membranes containing A2AR were solubilized with DDM
in solubilization buffer [50 mM Tris/HCl, 10 % glycerol, 500 mM
NaCl, 2.5 % (w/v) DDM, 0.5 % (w/v) cholesteryl hemi-succinate,
plus complete EDTA-free protease inhibitor cocktail (Roche),
pH 8.0] with a final concentration of 40 mg/ml (wet weight).
After incubation with slow rotation at 4 ◦C for 2 h, the sample
was centrifuged at 100 000 g for 1 h at 4 ◦C to remove the non-
solubilized material. For HEK293T cells, a crude membrane
preparation was prepared as described previously [20] and the
protein concentration determined using the BCA protein assay
kit (Pierce) using BSA as standard. A2AR-expressing membranes
(final protein concentration 0.5 mg/ml) were incubated with sol-
ubilization buffer (20 mM HEPES, 1mM EGTA,1 mM mag-
nesium acetate, 2.5 % (w/v) DDM, 0.5 % (w/v) cholesteryl hemi-
succinate, plus complete EDTA-free protease inhibitor cocktail
(Roche) for 3 h at 4 ◦C.
Ni2 + –NTA affinity purification
The SMA-solubilized preparation was recirculated through a
HisTrap HP 1 ml Ni2 + –NTA (nitrilotriacetate) Sepharose (GE
Healthcare) overnight at 4 ◦C. The column was washed with
20 column volumes (cv) of 50 mM Tris/HCl, pH 8.0, 500 mM
NaCl, 10 % glycerol, 20–60 mM imidazole, complete EDTA-free
protease inhibitor. Elution of the A2AR–SMALP was achieved
using 250 mM imidazole (10 cv) collected in 0.5 ml fractions.
Eluted fractions containing A2AR–SMALP were pooled, dialysed
overnight against buffer (50 mM Tris/HCl, 150 mM NaCl, 10 %
glycerol, complete protease inhibitor then concentrated using a
centrifugal concentrator (Vivaspin 20, 30 kDa cut-off, Sigma)).
Western blotting analysis used a primary anti-histidine antibody
(Takara Bio Europe) and an anti-mouse-HRP (horseradish perox-
idase; NEB) secondary antibody (both at 1:5000 dilution) visu-
alized using a chemiluminescence detection kit (Geneflow).
Radioligand-binding assays
Competition radioligand-binding assays with A2AR–SMALP
used [3H]ZM241385 (1 nM) as tracer ligand plus competing lig-
and at the concentrations indicated in a final volume of 250 μl.
Non-specific binding was defined by unlabelled ZM241385
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(1 μM). After incubation at 30 ◦C for 30 min to establish equi-
librium, bound and free ligand were separated by P30 mini-
spin gel filtration columns (1000 g, 4 min). Bound ligand in the
void volume was quantified by liquid scintillation counting using
a Packard Tri-Carb Liquid Scintillation Counter with HiSafe3
(Perkin–Elmer) as cocktail. Binding data were analysed by non-
linear regression to fit theoretical Langmuir binding isotherms
(with Hill slopes constrained to unity) to the experimental data
using PRISM (Graphpad Software Inc.). Ki values were cal-
culated from IC50 values using the Cheng–Prusoff equation to
correct for radioligand occupancy [21].
Gel filtration analysis
Gel filtration experiments were performed at 20 ◦C using a Super-
dex 200 10/300 GL column pre-equilibrated with buffer (50 mM
Tris, 300 mM NaCl, pH 8.0) on an ¨AKTA Purifier system (GE
Healthcare) with a flow rate of 1 ml/min. All experiments were
performed using 50 mM Tris, pH 8, with 300 mM NaCl using
a flow rate of 1 ml/min. The column was calibrated using the
standards ovalbumin (43 kDa), canalbumin (75 kDa), aldolase
(158 kDa), ferritin (440 kDa) and thyroglobulin (669 kDa) (GE
Healthcare).
CD
Data between 260 and 195 nm were collected using a JASCO
J-715 Spectrapolarimeter with a 1 mm path length cuvette con-
taining 0.05 mg/ml protein. Each spectrum was collected with a
data pitch of 0.5 nm and represents the average of eight scans.
Data were also collected using the same parameters for cuvettes
containing the relevant buffer to allow subtraction of the buffer
contribution.
Sedimentation velocity analytical
ultracentrifugation
Purified A2AR–SMALP equilibrated in 10 mM sodium phos-
phate, pH 8.0, was characterized by analytical ultracentrifugation
(AUC). Velocity experiments were performed using a Beckman
Coulter XL-I analytical ultracentrifuge (Beckman 693 Coulter)
with a Ti50 rotor at 40000 rpm (129 000 g) at 4 ◦C. The protein
within the cell was monitored by absorbance at 280 nm. Data
were then analysed using the c(S) and c(M) routines implemen-
ted within SEDFIT, a sedimentation data-fitting program [22].
Parameters for A2AR vbar and solvent density and viscosity were
calculated using SEDNTERP, a sedimentation interpretation pro-
gram [23].
RESULTS AND DISCUSSION
Detergent-free purification of the A2AR expressed in
yeast using SMALPs
The yeast P. pastoris has been utilized extensively to overexpress
a wide range of membrane proteins from a variety of organisms,
Table 1 Pharmacological characterization of A2AR–SMALP from
P. pastoris
For each ligand, the pKi value is presented for binding to A2AR ex-
pressed in P. pastoris membranes and also A2AR–SMALP generated
from the P. pastoris membranes. Data are mean +− S.E.M. (n = 3).
Ligand Yeast membrane Yeast-SMALP
ZM241385 7.95+−0.45 7.79+−0.14
XAC 6.53+−0.24 7.16+−0.18
NECA 5.66+−0.26 5.43+−0.1
Theophylline 3.82+−0.30 4.13+−0.1
including GPCRs for crystallization [24,25]. A histidine-tagged
human A2AR was expressed in a genetically-engineered strain
of P. pastoris, developed specifically for high-level expression of
recombinant membrane protein [26], using culture conditions op-
timized for production of functional receptor. A2AR-expressing
yeast cells were disrupted [16], then directly solubilized with
2.5 % (w/v) SMA co-polymer in the total absence of detergent.
The membrane pellet visibly clarified upon exposure to SMA
due to SMALP formation. Following removal of non-solubilized
material by centrifugation (100 000 g, 1h), the A2AR–SMALP
was purified using Ni2 + –NTA linked agarose (Figure 1a). The
A2AR eluted as a single band in fractions containing 250 mM
imidazole. The identity of the band as the A2AR was confirmed
by Western blotting using anti-histidine antibody to detect the
histidine-tagged A2AR (Figure 1b) and partial sequencing of the
purified protein using Fourier-transform ion cyclotron resonance
(FTICR) MS. The FTICR identified three peptides YNGLVT-
GTR, QMESQPLPGER and SHVLRQQEPFK corresponding to
A2AR residues 112–120 (part of intracellular loop 2), 210–220
(part of intracellular loop 3) and 305–315 (part of the C-terminal
tail) respectively.
Radioligand-binding assays with [3H]ZM241385 established
that the binding (Bmax) of the purified A2AR–SMALP preparation
was 20 100 pmol/mg protein, consistent with the theoretical value
for fully active receptor (21 300 pmol/mg protein), compared with
9.5 pmol/mg protein in the original yeast membrane. Competi-
tion ligand binding assays using a range of ligands with A2AR–
SMALP were consistent with established A2AR pharmacology
(International Union of Pharmacology (IUPHAR) database) and
comparable to A2AR binding in the original yeast membranes
(Table 1).
Several nanoscale self-assembly reagent systems have
been reported for purifying membrane proteins including bi-
celles, amphipols, scaffolding protein-stabilized nanodiscs and
SMALPs [27]. However, of these, only SMALP-solubilization of
GPCRs; (i) avoids exposure to detergent at any stage, (ii) pre-
serves the native composition of the annular lipid in close as-
sociation with the receptor and (iii) retains the lateral pressure
exerted within the membrane bilayer that has been shown to be
important for maintaining the conformation of membrane pro-
teins [28]. Previous studies have shown that membrane proteins
could be SMALP-solubilized from prokaryotes, such as archaea
and bacteria [15,29] and also from eukaryotic cells [30], but this
is the first report that a GPCR can be SMALP-solubilized and
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Figure 1 Purification of SMALP-solubilized His-tagged A2AR from P. pastoris
(a) The A2AR eluted from the Ni2+ –NTA linked agarose as a single band in silver-stained fractions with 250 mM imidazole.
(b) Western blot of the 250 mM imidazole fraction with an anti-histidine antibody.
furthermore that the active receptor can be purified to homo-
geneity as a GPCR–SMALP without the use of detergent at any
stage.
Increased thermostability of A2AR–SMALP
compared with detergent-solubilized A2AR
An acknowledged common problem with detergent solubiliza-
tion of GPCRs is destabilization of the receptor in the deter-
gent micelle compared with the native plasma membrane. As
the A2AR–SMALP preserves the annular lipid in close contact
with the receptor in the membrane, it was reasoned that A2AR
would be more thermostable in a SMALP than when detergent-
solubilized by DDM, a widely employed detergent for GPCR
solubilization. The antagonist [3H]ZM241385 is widely used to
quantify functional A2AR-binding capability using radioligand-
binding assays. A2AR–SMALP and DDM-solubilized A2AR from
P. pastoris membranes were incubated in parallel at various tem-
peratures and then the residual specific binding of [3H]ZM241385
was determined. From data presented in Figure 2, it can be seen
that the SMALP conferred a marked increase in A2AR thermo-
stability of ∼5.5 ◦C over the detergent micelle, with the T50 value
increasing from T50 = 44.4 +− 0.27 ◦C (n = 3) for A2AR–DDM to
T50 = 49.9 +− 1.19 ◦C (n = 3) for A2AR–SMALP.
Biophysical characterization of purified
A2aR–SMALP
Characterization of the A2AR–SMALP by size-exclusion chro-
matography revealed a mono-dispersed particle (Figure 3a). Ana-
lysis of the main peak by SDS/PAGE revealed a single protein
band (Figure 3b) with a migration consistent with the A2AR (com-
pare with Figure 1). AUC of the A2AR–SMALP confirmed the
presence of a single major particle species with a sedimentation
coefficient of 2.3S (Figure 3c).
The vast majority of membrane proteins stabilized in nan-
odiscs to-date have used the MSP-based system developed by
Figure 2 Thermostability of A2AR–SMALP and DDM-solubilized
A2AR from P. pastoris
A2AR–SMALP () and DDM-solubilized A2AR () prepared from P. pastoris
overexpressing A2aR were incubated for 30 min at the stated temper-
atures, chilled on ice, before specific binding of [3H]ZM241385 was
determined as described in ‘Methods’. Data are expressed as spe-
cific binding relative to the 20 ◦C data point (mean +− S.E.M. of three
separate experiments performed in triplicate).
Sligar and colleagues [12]. In this MSP method, the lipid disc
is stabilized by an annulus of scaffolding proteins which can in-
terfere with spectrophotometric studies on the embedded mem-
brane protein of interest. In contrast, the lipid disc in our SMALP
system is stabilized by a non-proteinacious polymer, which we
have already shown in a previous study, does not suffer from
the same limitations [15]. This allowed the conformation of the
SMALP-encapsulated A2AR to be studied using CD spectro-
scopy. It is known from solved crystal structures that the A2AR
possesses a high α-helix content due to the seven transmembrane
helical bundle that is a conserved feature of GPCR architec-
ture [31,32]. The far-UV (195–260 nm) CD spectrum of purified
A2AR–SMALP showed negative minima at 208 and 222 nm con-
sistent with a folded protein containing a high degree of α-helix
(Figure 4), consistent with the known secondary structure con-
tent of the A2AR. In contrast, an unfolded protein would have a
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Figure 3 Analysis of A2AR–SMALP from P. pastoris by size-exclusion chromatography and AUC
(a) elution profile of A2AR–SMALP from a Superdex 200 10/300GL size exclusion column with absorbance measured at
280 nm. (b) silver stained SDS/PAGE of the main peak eluted from the size exclusion chromatography. (c) plot of c(S)
compared with sedimentation coefficient for A2AR–SMALP.
negative minimum at 200 nm. CD was also used to assess the
thermal stability of the encapsulated A2AR. These data show that
as the temperature increases from 25 ◦C to 95 ◦C the intensity of
the 208 and 222 nm features reduces until at 95 ◦C the intensity
is less than 50 % of that observed at low temperature. This in-
dicates that the protein is steadily losing secondary structure as
the temperature increases. Closer examination of the CD spectra
shows a single isodichroic point at ∼201 nm. This indicates that
the thermal denaturation process is a two state process most prob-
ably correlating with a folded to unfolded transition. Comparison
of the CD spectra in Figure 4 to the thermostability binding data
(Figure 2) revealed that the change in the CD spectrum observed
between 25 ◦C and 65 ◦C reflected the structural changes under-
lying the complete loss of [3H]ZM241385 binding by the A2AR.
The A2AR was not fully denatured when the radioligand-binding
capability was lost; however, as α-helix content was still apparent
in the CD spectrum at 65 ◦C. The proportion of α-helix decreased
further as the temperature was raised from 65 ◦C to 95 ◦C but even
at 95 ◦C the A2AR CD signal had not completely changed to that
of a random coil (characterized by an intense negative signal
at 200 nm and a positive signal at 218 nm [33]). This indicates
that the helical secondary structure of the A2AR is resistant to
thermal denaturation in SMALPs. Retention of α-helical content
has also been reported for rhodopsin during denaturation stud-
ies with combinations of different denaturants. Furthermore, it
was concluded that surface elements within the rhodopsin struc-
ture were susceptible to denaturation, becoming more flexible
[34], whereas a cluster of interconnected segments from multiple
transmembrane helices preserved a rigid core [35]. This could
explain our observations on the effect of increasing temperature
on the A2AR structure and function. Molecular dynamics simu-
lations indicate that the process of a ligand binding to its cognate
GPCR progresses through an intermediate state in which the lig-
and binds initially to an extracellular vestibule prior to docking in
the classical ‘orthosteric’-binding site [36,37]. The rhodopsin un-
folding studies cited above indicate that surface elements within
the A2AR architecture would be more susceptible to structural per-
turbation than the relatively rigid α-helical core. This suggests a
feasible mechanism for our observations that the ligand-binding
capability of the A2AR was lost at temperatures which preserved
significant α-helical content, albeit lower than native A2AR. If
the conformations of extracellular structural elements that con-
tribute to the approach of a ligand to the orthosteric-binding site
via the extracellular vestibule were susceptible to thermal dis-
ruption, then ligand binding capability would be ablated but core
α-helical structure would be largely retained.
Characterization of A2AR–SMALP from transfected
HEK293T cells
The utility of SMALPs for purifying a functional human GPCR
from P. pastoris for investigation by biophysical approaches has
been demonstrated above. However, the exact lipid composition
of the yeast plasma membrane is different from mammalian cells,
most notably perhaps in lacking cholesterol and possessing er-
gosterol [38]. The nature of the lipids juxtaposed to a GPCR can
affect the function. For example, cholesterol can modulate the
activity of some GPCRs [39,40], can affect receptor conforma-
tion [41] and has been co-crystallized with GPCRs, which led
to a ‘cholesterol consensus motif’ being proposed as part of a
specific cholesterol-binding site within the architecture of some
GPCRs [42]. As the SMALP-solubilization process involves the
SMA polymer excising the receptor embedded in a nanodisc of
native membrane bilayer [15] the lipid composition preserved
in the A2AR–SMALP is dictated by the composition of the cell
membrane in which the receptor was expressed. There will be
instances, such as drug discovery assays, when it will be desir-
able to preserve the more physiological annular lipid composition
provided by a mammalian cell membrane. Consequently, we also
characterized A2AR–SMALP from transfected HEK293T cells.
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Figure 4 The effect of temperature on A2aR structure revealed by CD spectra of purified A2aR–SMALP
CD spectra were collected using a 1-mm path length cuvette and averaged over eight scans in the far-UV region
(195–260 nm). Spectra were corrected for the buffer signal.
Table 2 Pharmacological characterization of A2AR–SMALP from
HEK293T cells
For each ligand, the pKi value is presented for binding to A2AR
in HEK293T membranes and also A2AR–SMALP generated from the
HEK293T cell membranes. Data are mean +− S.E.M. (n = 3).
Ligand HEK membranes HEK–SMALP
ZM241385 8.87+−0.1 8.53+−0.04
XAC 7.17+−0.19 6.38+−0.16
NECA 5.29+−0.1 5.39+−0.41
Theophylline 4.87+−0.12 4.97+−0.27
HEK293T cells, expressing A2AR, were directly solubil-
ized with 2.0 % (w/v) SMA, in the total absence of deter-
gent, to generate a functional A2AR–SMALP preparation of
2.0 +− 0.24 pmol/mg protein (n = 3), equivalent to 23.3 +− 2.75 %
(n = 3) recovery of A2AR. Characterization of this A2AR–SMALP
by competition radioligand-binding using a range of ligands with
[3H]ZM241385 as tracer confirmed retention of typical A2AR
pharmacology (Table 2). The A2AR–SMALP from HEK293T
cells exhibited an increase in thermostability of 4 ◦C compared
with the corresponding detergent (DDM)-solubilized A2AR (Fig-
ure 5), with the T50 value increasing from T50 = 36.2 +− 0.52 ◦C
(n = 3) for A2AR–DDM to T50 = 40.2 +− 0.44 ◦C (n = 3)
for A2AR–SMALP. The A2AR–SMALP was not as stable as
A2AR embedded in the native HEK293T cell membrane however
(Figure 5).
Given the potential utility of the GPCR–SMALP for receptor-
based in vitro assays and screens, the stability of the A2AR–
SMALP at the physiological temperature of 37 ◦C and the stor-
age temperature of 4 ◦C was investigated together with the resist-
ance to repeated freeze-thaw cycles. A comparison of the loss
of ligand binding capability of the A2AR at 37 ◦C with time
is presented in Figure 6 for A2AR–DDM, A2AR–SMALP and
Figure 5 Thermostability of A2aR–SMALP, DDM-solubilized A2aR
and membrane-bound A2aR prepared from HEK293T cells
A2aR–SMALP (), DDM-solubilized A2aR () or membranes (), pre-
pared from HEK293T cells transfected with A2aR, were incubated for
30 min at the stated temperatures, then chilled on ice, before specific
binding of [3H]ZM241385 was determined as described in ‘Methods’.
Data are expressed as specific binding relative to the 20 ◦C data point
(mean +− S.E.M. of three separate experiments performed in triplicate).
cell membranes. The improved stability of the A2AR–SMALP
over A2AR–DDM at 37 ◦C is very marked, with a 7-fold in-
crease in the half-life of [3H]ZM241385 binding (A2AR–DDM,
t 1
2
= 21 +− 7 min; A2AR–SMALP, t 12 = 148 +− 13 min). This im-
provement is particularly apparent after 1 h, with no specific
binding detected for the detergent-solubilized receptor, whereas
85 +− 5 % of the binding was retained in the A2AR–SMALP (Fig-
ure 6). Although receptor stability was increased in the SMALP,
it did not match receptor stability in the native HEK293T mem-
branes at 37 ◦C, suggesting that not all the stabilizing factors
of the plasma membrane are incorporated into SMALPs. In
contrast, the stability of A2AR–SMALP at 4 ◦C was essentially
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Figure 6 Comparison of A2aR stability in different preparations
at 37C and 4C
A2aR–SMALP (), DDM-solubilized A2aR () or membranes (), pre-
pared from HEK293T cells transfected with A2aR, were incubated at
37 ◦C (top panel) or 4 ◦C (bottom panel), for the stated times. Specific
binding of [3H]ZM241385 was determined at each time point. Data are
expressed as specific binding relative to time zero (mean +− S.E.M. of
three separate experiments performed in triplicate).
indistinguishable from that of membranes with t 1
2
16 days,
whereas A2AR–DDM exhibited a t 1
2
= 1.8 +− 0.3 days (mean+− S.E.M.). The resilience of A2AR–SMALP was also evid-
ent from repeated freeze/thaw cycles (Figure 7). Even after
five freeze/thaw cycles on the same sample, there was no
decrease in [3H]ZM241385 binding capability of the A2AR–
SMALP. In contrast, specific binding to the A2AR–DDM
preparation was completely lost after a single freeze-thaw
cycle. Our data indicate that it is feasible to SMALP solu-
bilize GPCRs and store them at 4 ◦C until required. Interest-
ingly, the increase in thermostability endowed on A2aR by the
SMALP compared with DDM was approximately 5 ◦C for both
yeast and HEK 293T, suggesting that the increased thermo-
stability is an inherent property of the SMALP rather than
due to differences in the lipid composition of the original
membrane.
Figure 7 Effect of repeated freeze-thaw cycles on A2aR–SMALP
binding capability
A2aR–SMALP was subjected to repeated freeze/thaw cycles and spe-
cific binding of [3H]ZM241385 determined after each cycle. Data are
expressed as specific binding relative to binding before freezing (mean
+− S.E.M. of three separate experiments performed in triplicate).
CONCLUSION
Strategies to ameliorate the detrimental effect of exposing GPCRs
to detergents have included; modifying the detergent to reduce
perturbation to the receptor [4], modifying the receptor to in-
crease stability to detergent either by alanine scanning [43] or by
molecular evolution [44] and simply reducing the detergent ex-
posure time by inserting the detergent-solubilized receptor into
nanodiscs stabilized by scaffolding proteins [9]. However, the
ideal option would be to extract GPCR from the membrane,
for purification or downstream assays, without the requirement
for detergent. In the present study, we report the first purifica-
tion of a GPCR (human A2aR), without exposure to detergent at
any stage, by exploiting spontaneous encapsulation direct from a
membrane into a nanoscale SMALP. The A2AR–SMALP, gener-
ated from both yeast and mammalian cells, exhibited increased
thermostability compared with DDM-solubilized receptor that
will facilitate use in receptor-based assays/screens. Furthermore,
in contrast with nanodiscs stabilized by scaffold proteins, the
non-proteinaceous nature of the SMA polymer does not interfere
with biophysical characterization of the embedded receptor.
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